Testing effectiveness (Phase 2)Study completedNCT04154488
What this trial is testing
Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders
Who this might be right for
Neutropenia
X4 Pharmaceuticals 32
Showing 5 of 5 results